JP2002508781A5 - - Google Patents

Download PDF

Info

Publication number
JP2002508781A5
JP2002508781A5 JP1999507009A JP50700999A JP2002508781A5 JP 2002508781 A5 JP2002508781 A5 JP 2002508781A5 JP 1999507009 A JP1999507009 A JP 1999507009A JP 50700999 A JP50700999 A JP 50700999A JP 2002508781 A5 JP2002508781 A5 JP 2002508781A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1999507009A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002508781A (ja
Filing date
Publication date
Priority claimed from SE9702533A external-priority patent/SE9702533D0/xx
Application filed filed Critical
Publication of JP2002508781A publication Critical patent/JP2002508781A/ja
Publication of JP2002508781A5 publication Critical patent/JP2002508781A5/ja
Ceased legal-status Critical Current

Links

JP50700999A 1997-07-01 1998-06-22 発泡性マルチユニット製剤形 Ceased JP2002508781A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9702533-2 1997-07-01
SE9702533A SE9702533D0 (sv) 1997-07-01 1997-07-01 New oral formulation
PCT/SE1998/001209 WO1999001112A1 (en) 1997-07-01 1998-06-22 Multiple unit effervescent dosage form

Publications (2)

Publication Number Publication Date
JP2002508781A JP2002508781A (ja) 2002-03-19
JP2002508781A5 true JP2002508781A5 (enExample) 2005-12-22

Family

ID=20407594

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50700999A Ceased JP2002508781A (ja) 1997-07-01 1998-06-22 発泡性マルチユニット製剤形

Country Status (9)

Country Link
US (1) US6284271B1 (enExample)
EP (1) EP1014952B1 (enExample)
JP (1) JP2002508781A (enExample)
AT (1) ATE247952T1 (enExample)
AU (1) AU733801B2 (enExample)
CA (1) CA2294744C (enExample)
DE (1) DE69817587T2 (enExample)
SE (1) SE9702533D0 (enExample)
WO (1) WO1999001112A1 (enExample)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US20050054682A1 (en) * 1996-01-04 2005-03-10 Phillips Jeffrey O. Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
DE19850309A1 (de) * 1998-10-30 2000-05-04 Lohmann Therapie Syst Lts Expandierbares gastroretensives Therapiesystem mit verlängerter Magenverweildauer
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
WO2001058424A1 (en) * 2000-02-09 2001-08-16 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Floating drug delivery composition
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
AU2001296908A1 (en) * 2000-09-29 2002-04-08 Geneva Pharmaceuticals, Inc. Proton pump inhibitor formulation
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
WO2002064093A2 (en) 2001-02-15 2002-08-22 King Pharmaceuticals, Inc. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
DE10111780B8 (de) * 2001-03-13 2005-02-10 Isaak Dr. Abramov Brausetablette, Pille oder Dragee, sowie das Verfahren zu ihrer Herstellung
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20030171436A1 (en) * 2001-10-29 2003-09-11 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
MXPA04007169A (es) * 2002-01-25 2004-10-29 Santarus Inc Suministro transmucosal de inhibidores de bomba de protones.
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
WO2004056336A2 (en) * 2002-12-20 2004-07-08 Ranbaxy Laboratories Limited Controlled release, multiple unit drug delivery systems
EP2359817B1 (en) * 2003-03-28 2018-01-10 Sigmoid Pharma Limited Solid oral dosage form containing seamless microcapsules
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
CA2579767A1 (en) * 2004-04-30 2005-11-10 Astellas Pharma Inc. Oral pharmaceutical composition in timed-release particle form and fast-disintegrating tablets containing this composition
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
DE602005010899D1 (de) * 2004-09-27 2008-12-18 Sigmoid Pharma Ltd Mikrokapseln mit einem methylxanthin und einem kortikosteroid
GB0427455D0 (en) * 2004-12-15 2005-01-19 Jagotec Ag Dosage forms
US7981908B2 (en) * 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) * 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
KR100674622B1 (ko) * 2005-11-04 2007-01-29 재단법인 포항산업과학연구원 연료전지 발전시스템
FR2902337B1 (fr) * 2005-12-02 2010-09-17 Vacher Dominique Comprimes a liberation immediate et leur production
EP2026768B1 (en) * 2006-06-01 2018-02-28 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
DK2046334T3 (da) * 2006-07-25 2014-08-25 Vecta Ltd Sammensætninger og fremgangsmåder til at hæmme mavesyresekretion ved at anvende derivater af små dicarboxylsyrer i kombination med PPI
RU2420268C2 (ru) * 2006-09-04 2011-06-10 Панацея Биотек Лимитед Способ программируемой плавучей доставки
GB2459393B (en) * 2006-10-05 2010-09-08 Santarus Inc Novel capsule formulation for the proton pump inhibitor omeprazole
CN103120653B (zh) * 2007-04-04 2015-09-30 希格默伊德药业有限公司 一种口服药物组合物
US8951570B2 (en) * 2007-04-26 2015-02-10 Sigmoid Pharma Limited Manufacture of multiple minicapsules
JP2010526054A (ja) * 2007-05-01 2010-07-29 シグモイド・ファーマ・リミテッド 併用医薬組成物
HUP0700469A2 (en) * 2007-07-09 2009-04-28 Richter Gedeon Nyrt Floating pharmaceutical composition of sustained release containing metronidazol
US20120276206A1 (en) * 2008-03-28 2012-11-01 Boehringer Ingelheim International Gmbh Method for manufacturing acid pellets
PL2471518T3 (pl) 2009-05-18 2018-01-31 Sigmoid Pharma Ltd Kompozycja zawierająca kropelki oleju
FR2945947B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
FR2949061B1 (fr) * 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
BR112012002963A2 (pt) 2009-08-12 2017-10-24 Sigmoid Pharma Ltd composições imunomoduladoras compreendendo uma matriz de polímero e uma fase oleosa
GB2481005B (en) * 2010-06-07 2012-08-08 Cosmetic Warriors Ltd Surfactant product comprising first and second effervescent materials
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
WO2014191806A2 (en) * 2013-05-02 2014-12-04 Effrx Pharmaceuticals Sa Effervescent formulations that deliver particles which float in the stomach
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
PL3215127T3 (pl) 2014-11-07 2021-05-17 Sublimity Therapeutics Limited Kompozycje zawierające cyklosporynę
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
KR20170003414A (ko) * 2015-06-30 2017-01-09 (주)아모레퍼시픽 속붕해형 과립환 모발 세정용 조성물
EP3167879A1 (en) * 2015-11-10 2017-05-17 Evonik Technochemie GmbH Gastric retention active delivery systems
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2025235402A1 (en) 2024-05-07 2025-11-13 Herbalife International Of America, Inc. Compositions and methods for effervescent systems with improved stability

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5512411B2 (enExample) 1974-03-12 1980-04-02
SE450087B (sv) 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
JPS62195323A (ja) * 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
US4814178A (en) 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5445826A (en) 1988-06-28 1995-08-29 Cibus Pharmaceutical, Inc. Delivery system containing a gel-forming dietary fiber and a drug
GB9224021D0 (en) 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US5503846A (en) 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
EP0667149A1 (en) 1994-02-14 1995-08-16 E-PHARMA TRENTO S.p.A. Ibuprofen based effervescent composition
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
ATE182073T1 (de) 1994-03-01 1999-07-15 Gerhard Gergely Ein brausesystem und einen arzneiwirkstoff enthaltendes granuläres produkt bzw. tablette sowie verfahren zu deren herstellung
IE940292A1 (en) 1994-04-06 1995-10-18 Elan Corp Plc Biodegradable microcapsules and method for their manufacture
ATE206044T1 (de) 1994-07-08 2001-10-15 Astrazeneca Ab Aus mehreren einzeleinheiten zusammengesetzte dosierungsform in tablettenform (i)
SE9402422D0 (sv) 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
SE512835C2 (sv) 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare

Similar Documents

Publication Publication Date Title
JP2000507042A5 (enExample)
JP2000510751A5 (enExample)
JP2000509942A5 (enExample)
JP2000509637A5 (enExample)
JP2000509635A5 (enExample)
JP2002508784A5 (enExample)
JP2001527689A5 (enExample)
JP2002500650A5 (enExample)
JP2000509587A5 (enExample)
JP2000507369A5 (enExample)
JP2000507433A5 (enExample)
JP2002508781A5 (enExample)
JP2000508866A5 (enExample)
JP2000508841A5 (enExample)
JP2002507940A5 (enExample)
JP2001523225A5 (enExample)
JP2002508712A5 (enExample)
JP2001513834A5 (enExample)
JP2001523162A5 (enExample)
JP2001512965A5 (enExample)
JP2000509804A5 (enExample)
JP2000509853A5 (enExample)
JP2000509755A5 (enExample)
JP2000510247A5 (enExample)
JP2000508836A5 (enExample)